Effects of essential oil components exposure on biological parameters of Caenorhabditis elegans

2021 ◽  
pp. 112763
Author(s):  
Cristina Fuentes ◽  
Samuel Verdú ◽  
Ana Fuentes ◽  
María José Ruiz ◽  
José Manuel Barat
2020 ◽  
Vol 113 (5) ◽  
pp. 2436-2447
Author(s):  
S O Oladipupo ◽  
X P Hu ◽  
A G Appel

Abstract The use of essential oil components (EOCs) against the German cockroach, Blattella germanica (L.), has increasingly received attention from researchers. However, the determination of lethal doses/concentrations alone does not provide enough information on the range of biological effects of these EOCs. To improve our understanding of the potential effects of EOCs, we examined biological parameters of B. germanica exposed to sublethal EOCs formulated in gels. This study employed superabsorbent polymer (SAP) gel to prolong bioavailability of limonene, carvacrol, and β-thujaplicin, and evaluated how these EOCs shape biological parameters of B. germanica. Overall, median survival days ranged from 57 to 69.5 d for males and 73 to 99 d for females. The survival day ranking for the EOCs was limonene > β-thujaplicin > carvacrol. Carvacrol and β-thujaplicin gels reduced male longevity by at least 34 and 39%, respectively, while limonene had no effect. The longevity of females was reduced by limonene, but not by carvacrol and β-thujaplicin gels. EOCs significantly suppressed overall adult females’ reproductive period, oothecal hatchability, reduced fecundity, and interoothecal period, but not the number of oothecae formed and egg incubation period. The preoviposition period (mean: 2–25 d) ranking was limonene < carvacrol < β-thujaplicin. Based on these results, limonene, carvacrol, and β-thujaplicin in SAP gels show promising potential to reduce adult male survival/longevity, suppress egg hatchability and female fecundity, and delay the interoothecal period. These findings may represent the basis for the practical use of EOCs as a tactic in integrated pest management systems for B. germanica.


Author(s):  
Yedy Purwandi Sukmawan ◽  
Kusnandar Anggadiredja ◽  
I Ketut Adnyana

Background: Neuropathic pain is one of the contributors to the global burdens of illness. At present many patients do not achieve satisfactory pain relief even with synthetic pain-killers. Taking this into consideration, it is necessary to search for natural product-derived alternative treatment with confirmed safety and efficacy. Ageratum conyzoides L is a plant often used as analgesic in Indonesia, however, anti-neuropathic pain activity of this plant is still unknown. Objective: To determine the anti-neuropathic pain activity of the essential oil and non-essential oil component (distillation residue) of A. conyzoides L. Methods: We conducted separation of the essential oil component from other secondary metabolites through steam distillation. Both components were tested for anti-neuropathic pain activity using chronic constriction injury animal models with thermal hyperalgesia and allodynia tests. The animals were divided into 7 test groups namely normal, sham, negative, positive (pregabalin at 0.195 mg/20 g BW of mice), essential oil component (100 mg/kg BW), and non-essential oil component (100 mg/kg BW). Naloxone was tested against the most potent anti-neuropathic pain component (essential oil or nonessential oil) to investigate the involvement of opioid receptor. Results: The GC-MS of the essential oil component indicated the presence of 60 compounds. Meanwhile, non-essential oil components contained alkaloid, flavonoid, polyphenol, quinone, steroid, and triterpenoid. This non-essential oil component contained a total flavonoid equivalent to 248.89 ppm quercetin. The anti-neuropathic pain activity test showed significantly higher activity of the essential oil component compared to the non-essential oil component and negative groups (p<0.05). Furthermore, the essential oil component showed equal activity to pregabalin (p>0.05). However, this activity was abolished by naloxone, indicating the involvement of opioid receptor in the action of the essential oil component. Conclusion: The essential oil component of A. conyzoides L is a potential novel substance for use as anti-neuropathic pain.


LWT ◽  
2021 ◽  
pp. 111881
Author(s):  
Jessica Audrey Feijó Corrêa ◽  
João Vitor Garcia dos Santos ◽  
Alberto Gonçalves Evangelista ◽  
Anne Caroline Schoch Marques Pinto ◽  
Renata Ernlund Freitas de Macedo ◽  
...  

2021 ◽  
Vol 281 ◽  
pp. 109964
Author(s):  
Halime Kahveci ◽  
Nilgun Bilginer ◽  
Emel Diraz-Yildirim ◽  
Muhittin Kulak ◽  
Emre Yazar ◽  
...  

2005 ◽  
Vol 68 (12) ◽  
pp. 2559-2566 ◽  
Author(s):  
SYLVIA GAYSINSKY ◽  
P. MICHAEL DAVIDSON ◽  
BARRY D. BRUCE ◽  
JOCHEN WEISS

Growth inhibition of four strains of Escherichia coli O157:H7 (H1730, F4546, 932, and E0019) and Listeria monocytogenes (Scott A, 101, 108, and 310) by essential oil components (carvacrol and eugenol) solubilized in nonionic surfactant micelles (Surfynol 465 and 485W) was investigated. Concentrations of encapsulated essential oil components ranged from 0.02 to 1.25% depending on compound, surfactant type, and surfactant concentration (0.5 to 5%). Eugenol encapsulated in Surfynol 485W micelles was most efficient in inhibiting growth of the pathogens; 1% Surfynol 485W and 0.15% eugenol was sufficient to inhibit growth of all strains of E. coli O157:H7 and three of four strains of L. monocytogenes (Scott A, 310, and 108). The fourth strain, L. monocytogenes 101, was inhibited by 2.5% Surfynol and 0.225% eugenol. One percent Surfynol 485W in combination with 0.025% carvacrol was effective in inhibiting three of four strains of E. coli O157:H7. Strain H1730 was the most resistant strain, requiring 0.3% carvacrol and 5% surfactant for complete inhibition. Growth inhibition of L. monocytogenes by combinations of carvacrol and Surfynol 465 ranged between 0.15 and 0.35% and 1 and 3.75%, respectively. Generally, the antimicrobial activity of Surfynol 465 in combination with eugenol was higher than that for the combination with carvacrol. The potent activity was attributed to increased solubility of essential oil components in the aqueous phase due to the presence of surfactants and improved interactions of antimicrobials with microorganisms.


2009 ◽  
Vol 1 (1) ◽  
Author(s):  
Jalal Khorshidi ◽  
Mohammad Fakhr Tabatabaie ◽  
Reza Omidbaigi ◽  
Fatemeh Sefidkon

Sign in / Sign up

Export Citation Format

Share Document